• Advertise
  • Contact Us
  • Subscribe
  • Follow
  • Follow
Pharmafile Logo
  • Home
  • Publications
    • European Biopharmaceutical Review
    • European Pharmaceutical Contractor (EPC)
    • Innovations in Pharmaceutical Technology (IPT)
    • International Clinical Trials (ICT)
    • Pharmaceutical Manufacturing and Packing Sourcer (PMPS)
    • Pharmafocus
    • Pharmafile
  • Conferences
  • News & Press Releases
  • Directory
  • Subscribe

PCI Pharma Services Announces European Clinical Site Expansion to Support Growth

Samedan Ltd|Sep 20, 2016| Uncategorized

Philadelphia, USA - September 20, 2016. Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI)...

CPhI Annual Report 2020 Part 1: 2025 will see cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China

CPhI Annual Report 2020 Part 1: 2025 will see cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China

Samedan Ltd|Sep 20, 2016| Uncategorized

Amsterdam, 16 September 2020:CPhI Annual Report - launched ahead of the first CPhI Festival of Pharma (5-16 October,...

Sterling Pharma Solutions launches following management buyout

Samedan Ltd|Sep 20, 2016| Uncategorized

UK-based Sterling Pharma Solutions has formed as an independent contract development and manufacturing organisation...

West to Feature Innovations in Injectable Drug Packaging and Delivery during CPhI InnoPack Worldwide 2016

Samedan Ltd|Sep 20, 2016| Uncategorized

Exton, Pa ó September 20, 2016 (Booth #2M22) - West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in...

Optibrium and The Edge Collaborate on Integration of StarDrop with BioRails

Samedan Ltd|Sep 20, 2016| Uncategorized

CAMBRIDGE, UK and GUILDFORD, UK, 20 September, 2016 - Optibrium™ and The Edge Software Consultancy, developers of...

Innova Biosciences Introduces AbPure Magnetic Purification System

Samedan Ltd|Sep 19, 2016| Uncategorized

Cambridge, UK, 19 September 2016: Innova Biosciences (Innova), a specialist provider of bioconjugation products and...

Plasticell and CellSpring collaborate to validate osteogenic cell therapy and 3D cell culture models for high performance drug screening

Samedan Ltd|Sep 19, 2016| Uncategorized

Stevenage, UK, 19 September 2016. Plasticell, the biotechnology company using combinatorial technologies for stem cell...

ERT Recognised for Patient-Focused Technological Development in Clinical Trials

Samedan Ltd|Sep 19, 2016| Uncategorized

PHILADELPHIA - September 19, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use...

Nanobiotix announces that Bpifrance has awarded the company an interest free loan

Samedan Ltd|Sep 19, 2016| Uncategorized

Paris, France, and Cambridge, Massachusetts, USA, September 19, 2016 - NANOBIOTIX (Euronext: NANO - ISIN:...

ERT Takes the Headache out of Migrane Drug Study

Samedan Ltd|Sep 19, 2016| Uncategorized

PHILADELPHIA - September 19, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use...

Lipoic acid shows great potential as a disease modifying treatment for secondary progressive MS: ECTRIMS congress

Samedan Ltd|Sep 17, 2016| Uncategorized

17 September 2016, London: The 32nd Congress of the European Committee for Treatment and Research in Multiple...

KCR Organises Patient Recruitment & Retention Days to Share its Knowledge and Experience

Samedan Ltd|Sep 15, 2016| Uncategorized

Berlin - 15 September 2016 - International Contract Research Organization (CRO) KCR announces its Patient Recruitment...

Older Entries
Next Entries
European Biopharmaceutical Review
European Pharmaceutical Contractor
Innovations in Pharmaceutical Technology
International Clinical Trials
Pharmaceutical Manufacturing and Packing Sourcer
Pharmafile
Pharmafile.com
Pharmafocus
  • About Samedan
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (UK)
All content copyright © Samedan Ltd 2026
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}